Abstract
Amongst all toxicological endpoints, carcinogenicity might pose the greatest concern. Genetic damage has been considered an important underlying mechanism for the carcinogenicity of chemical substances. The demand for in vitro genotoxic tests as alternative approaches is growing rapidly with the implementation of new regulations for compounds. However, currently available in vitro genotoxicity tests are often limited by relatively high false positive rates. Moreover, few studies have explored carcinogenicity potential by in vitro genotoxicity testing due to the shortage of suitable toxicological biomarkers to link gene damage with cancer risk. γ-H2AX is a recently acknowledged attractive endpoint (biomarker) for evaluating DNA damage and can simultaneously reflect the DNA damage response and repair of cells. We previously reported an ultrasensitive and reliable method, namely stable-isotope dilution-liquid chromatography–tandem mass spectrometry (ID-LC–MS/MS), for detecting cellular γ-H2AX and evaluating genotoxic chemicals. More importantly, our method can dynamically monitor the specific processes of genotoxic compounds affecting DNA damage and repair reflected by the amount of γ-H2AX. To clarify the possibility of using this method to assess the potential carcinogenicity of genotoxic chemicals, we applied it to a set of 69 model compounds recommended by the European Center for the Validation of Alternative Methods (ECVAM), with already-characterized genotoxic potential. Compared to conventional in vitro genotoxicity assays, including the Ames test, the γ-H2AX assay by MS has high accuracy (94–96%) due to high sensitivity and specificity (88% and 100%, respectively). The dynamic profiles of model compounds after exposure in HepG2 cells were explored, and a mathematical approach was employed to simulate and quantitatively model the DNA repair kinetics of genotoxic carcinogens (GCs) based on γ-H2AX time–effect curves up to 8 h. Two crucial parameters, i.e., k (rate of γ-H2AX decay) and t50 (time required for γ-H2AX from maximum decrease to half) estimated by the least squares method, were achieved. An open web server to help researchers calculate these two key parameters and profile simulated curves of the tested compound is available online (http://ccb1.bmi.ac.cn:81/shiny-server/sample-apps/prediction1/). We detected a positive association between carcinogenic levels and k and t50 values of γ-H2AX in tested GCs, validating the potential of using this MS-based γ-H2AX in vitro assay to help preliminarily evaluate carcinogenicity and assess genotoxicity. This approach may be used alone or integrated into an existing battery of in vitro genetic toxicity tests.
Similar content being viewed by others
Abbreviations
- 2,4-DAT:
-
2,4-Diaminotoluene
- 2-AAF:
-
2-Acetylaminofluorene
- 4-NQO:
-
4-Nitroquinoline-N-oxide
- 5-Fu:
-
5-Fluorouracil
- AFB1:
-
Aflatoxin B1
- ANOVA:
-
Analysis of variance
- Arac:
-
Cytosine arabinoside
- AZT:
-
Azidothymidine
- BaP:
-
Benzo[a]pyrene
- CA:
-
Chromosome aberration
- CdCl2 :
-
Cadmium chloride
- Cispt:
-
Cisplatin
- CPA:
-
Cyclophosphamide
- DMBA:
-
Dimethylbenzanthracene
- DMEM:
-
Dulbecco’s modified Eagle’s medium
- DMNA:
-
Dimethylnitrosamine
- DSB:
-
DNA double-strand break
- ECVAM:
-
European Center for the Validation of Alternative Methods
- ENU:
-
N-Ethyl-N-nitrosourea
- ESI:
-
Electrospray ionization
- ETOP:
-
Etoposide
- FBS:
-
Foetal bovine serum
- GCs:
-
Genotoxic carcinogens
- HepG2:
-
Human hepatoblastoma cells
- IARC:
-
International Agency for Research on Cancer
- ICH:
-
International Council for Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use
- ID-LC–MS/MS:
-
Isotope dilution-liquid chromatography–tandem mass spectrometry
- IQ:
-
2-Amino-3-methylimidazo(4,5-f)quinolone
- LC–MS/MS:
-
Liquid chromatography–tandem mass spectrometry
- k :
-
Rate of γ-H2AX decay
- LSD:
-
Least significant difference
- MEC:
-
Minimum effective concentration
- MECs:
-
Minimum effective concentrations
- MLA:
-
Mouse lymphoma assay
- MMC:
-
Mitomycin C
- MMS:
-
Methyl methanesulfonate
- MN:
-
Micronucleus
- MOA:
-
Mode of action
- MRM:
-
Multiple reaction monitoring
- NDCs:
-
Non-DNA damaging chemicals
- OECD:
-
Organization for Economic Co-operation and Development
- p-Chl:
-
p-Chloroaniline
- PHHs:
-
Primary human hepatocytes
- PhIP:
-
2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine
- RCC:
-
Relative cell counts
- SD:
-
Standard deviation
- t 50 :
-
Time required for γ-H2AX from maximum decrease to half
- t max :
-
Time to peak
- VICH:
-
International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Medicinal Products
- γ-H2AX:
-
Phosphorylated histone H2AX
References
Aardema MJ, Albertini S, Arni P, Henderson LM, Kirsch-Volders M, Mackay JM, Sarrif AM, Stringer DA, Taalman RDF (1998) Aneuploidy: a report of an ECETOC task force. Mutat Res 410(1):3–79
Audebert M, Riu A, Jacques C, Hillenweck A, Jamin EL, Zalko D, Cravedi JP (2010) Use of the γ-H2AX assay for assessing the genotoxicity of polycyclic aromatic hydrocarbons in human cell lines. Toxicol Lett 199(2):182–192
Birrell L, Cahill P, Hughes C, Tate M, Walmsley RM (2010) GADD45a-GFP GreenScreen HC assay results for the ECVAM recommended lists of genotoxic and non-genotoxic chemicals for assessment of new genotoxicity tests. Mutat Res 695(1–2):87–95
Butterworth BE (1990) Consideration of both genotoxic and nongenotoxic mechanisms in predicting carcinogenic potential. Mutat Res 239(2):117–132
Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G (2012) Molecular mechanisms of cisplatin resistance. Oncogene 31(15):1869–1883
Guo X, Seo JE, Li X, Mei N (2019) Genetic toxicity assessment using liver cell models: past, present, and future. J Toxicol Environ Health B Crit Rev 23(1):1–24
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674
Hendriks G, Derr RS, Misovic B, Morolli B, Calleja FM, Vrieling H (2016) The extended ToxTracker assay discriminates between induction of DNA damage, oxidative stress, and protein misfolding. Toxicol Sci 150(1):190–203
Hewitt NJ, Hewitt P (2004) Phase I and II enzyme characterization of two sources of HepG2 cell lines. Xenobiotica 34(3):243–256
Hughes C, Rabinowitz A, Tate M, Birrell L, Allsup J, Billinton N, Walmsley RM (2012) Development of a high-throughput gaussian luciferase reporter assay for the activation of the GADD45a gene by mutagens, promutagens, clastogens, and aneugens. J Biomol Screen 17(10):1302–1315
Ibuki Y, Toyooka T (2015) Evaluation of compound phototoxicity, focusing on phosphorylated histone H2AX. J Radiat Res 56(2):220–228
ICH (2011) Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use S2(R1). ICH Expert Working Group. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S2_R1/Step4 /S2R1_Step4.pdf. Accessed 12 Nov 2018
Jiang XJ, Chen CZ, Zhao W, Zhang ZZ (2013) Sodium arsenite and arsenic trioxide differently affect the oxidative stress, genotoxicity and apoptosis in A549 cells: an implication for the paradoxical mechanism. Environ Toxicol Pharmacol 36(3):891–902
Jurica K, Karačonji IB, Benković V, Kopjar N (2017) In vitro assessment of the cytotoxic, DNA damaging, and cytogenetic effects of hydroquinone in human peripheral blood lymphocytes. Arh Hig Rada Toksikol 68(4):322–335
Khoury L, Zalko D, Audebert M (2013) Validation of high-throughput genotoxicity assay screening using γ-H2AX in-cell western assay on HepG2 Cells. Environ Mol Mutagen 54(9):737–746
Kirkland D, Aardema M, Henderson L, Muller L (2005) Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat Res 584(1–2):1–256
Kirkland D, Kasper P, Martus H-J (2016) Updated recommended lists of genotoxic and non-genotoxic compounds for assessment of the performance of new or improved genotoxicity tests. Mutat Res 795(1):7–30
Kopp B, Dario M, Zalko D, Audebert M (2018) Assessment of a panel of cellular biomarkers and the kinetics of their induction in comparing genotoxic modes of action in HepG2 Cells. Environ Mol Mutagen 59(6):516–528
Kopp B, Khoury L, Audebert M (2019) Validation of the γH2AX biomarker for genotoxicity assessment: a review. Arch Toxicol 93(8):2103–2114
Lee Y, Wang Q, Shuryak I, Brenner DJ, Turner HC (2019) Development of a high-throughput γ-H2AX assay based on imaging flow cytometry. Radiat Oncol 14(1):150
Luch A (2005) Nature and nurture—lessons from chemical carcinogenesis. Nat Rev Cancer 5(2):113–125
MacGregor JT, Frotschl R, White PA, Crump KS, Eastmond DA, Fukushima S, Guerard M, Hayashi M, Soeteman-Hernandez LG, Johnson GE, Kasamatsu T, Levy DD, Morita T, Müller L, Schoeny R, Schuler MJ, Thybaud V (2015) IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk. Mutat Res 783(5):66–78
Matsuzaki K, Harada A, Takeiri A, Tanaka K, Mishima M (2010) Whole cell-ELISA to measure the gammaH2AX response of six aneugens and eight DNA-damaging compounds. Mutat Res 700(1–2):71–79
Motoyama S, Takeiri A, Tanaka K, Harada A, Matsuzaki K, Taketo J, Matsuo S, Fujii E, Mishima M (2018) Advantages of evaluating γ-H2AX induction in non-clinical drug development. Genes Environ 40:10
Mumbrekar KD, Goutham HV, Vadhiraja BM, Bola Sadashiva SR (2016) Polymorphisms in double strand break repair related genes influence radiosensitivity phenotype in lymphocytes from healthy individuals. DNA Repair (amst) 40(4):27–34
Nagel ZD, Engelward BP, Brenner DJ, Begley TJ, Sobol RW, Bielas JH, Stambrook PJ, Wei Q, Hu JJ, Terry MB, Dilworth C, McAllister KA, Reinlib L, Worth L, Shaughnessy DT (2017) Towards precision prevention: technologies for identifying healthy individuals with high risk of disease. Mutat Res 800–802(8):14–28
Nohmi T (2018) Thresholds of genotoxic and non-genotoxic carcinogens. Toxicol Res 34(4):281–290
OECD (2015) Guidance document on revisions to OECD genetic toxicology test guidelines. OECD Workgroup of National Coordinators for Test 42 guidelines (WNT). https://www.oecd.org/chemicalsafety/testing/Genetic%20Toxicology%20Guidance%20Document%20Aug%2031%202015.pdf. Accessed 12 Nov 2018
Qu MM, Xu H, Chen J, Zhang YJ, Xu B, Guo L, Xie JW (2020) Distinct orchestration and dynamic processes on γ-H2AX and p-H3 for two major types of genotoxic chemicals revealed by mass spectrometry analysis. Chem Res Toxicol 33(8):2108–2119
Rocejanasaroj A, Tencomnao T, Sangkitikomol W (2014) Thunbergia laurifolia extract minimizes the adverse effects of toxicants by regulating P-glycoprotein activity, CYP450, and lipid metabolism gene expression in HepG2 cells. Genet Mol Res 13(1):205–219
Rothkamm K, Barnard S, Moquet J, Ellender M, Rana Z, Burdak-Rothkamm S (2015) DNA damage foci: meaning and significance. Environ Mol Mutagen 56(6):491–504
Sanchez-Flores M, Pasaro E, Bonassi S, Laffon B, Valdiglesias V (2015) γH2AX assay as DNA damage biomarker for human population studies: defining experimental conditions. Toxicol Sci 144(2):406–413
Sharma PM, Ponnaiya B, Taveras M, Shuryak I, Turner H, Brenner DJ (2015) High throughput measurement of gammaH2AX DSB repair kinetics in a healthy human population. PLoS ONE 10(3):e0121083
Skipper A, Sims JN, Yedjou CG, Tchounwou PB (2016) Cadmium chloride induces DNA damage and apoptosis of human liver carcinoma cells via oxidative stress. Int J Environ Res Public Health 13(1):88
Smart DJ, Ahmedi KP, Harvey JS, Lynch AM (2011) Genotoxicity screening via the γH2AX by flow assay. Mutat Res 715(1–2):25–31
Stöber R (2018) Highlight report: false positives in genotoxicity testing. Arch Toxicol 92(7):2405
Takeiri A, Matsuzaki K, Motoyama S, Yano M, Harada A, Katoh C, Tanaka K, Mishima M (2019) High-content imaging analyses of gamma-H2AX-foci and micronuclei in TK6 cells elucidated genotoxicity of chemicals and their clastogenic/aneugenic mode of action. Genes Environ 41:4
Turkez H, Arslan ME, Ozdemir O (2017) Genotoxicity testing: progress and prospects for the next decade. Expert Opin Drug Metab Toxicol 13(10):1089–1098
VICH (2013) VICH topic GL23(R): studies to evaluate the safety of residues of veterinary drugs in human food: Genotoxicity testing. https://www.ema.europa.eu/documents/scientific-guideline/international-cooperation-harmonisation-technical-requirements-registration-veterinary -medic inal_en-2.pdf. Accessed 12 Nov 2018
Westerink WM, Stevenson JC, Horbach GJ, Schoonen WG (2010) The development of RAD51C, Cystatin A, p53 and Nrf2 luciferase reporter assays in metabolically competent HepG2 cells for the assessment of mechanism-based genotoxicity and of oxidative stress in the early research phase of drug development. Mutat Res 696(1):21–40
Wu S, Powers S, Zhu W, Hannun YA (2016a) Substantial contribution of extrinsic risk factors to cancer development. Nature 529(7584):43–47
Wu YF, Chitranshi P, Loukotková L, Costa GGD, Beland FA, Zhang J, Fang JL (2016b) Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells. Arch Toxicol 91(6):1–19
Yamada HY, Gorbsky GJ (2006) Spindle checkpoint function and cellular sensitivity to antimitotic drugs. Mol Cancer Ther 5(12):2963–2969
Zeilinger K, Freyer N, Damm G, Seehofer D, Knospel F (2016) Cell sources for in vitro human liver cell culture models. Exp Biol Med (maywood) 241(15):1684–1698
Funding
This work was supported by the National Key Research and Development Program (2018YFC1602600) and the National Natural Science Foundation of China (No. 21974151).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Qu, M., Xu, H., Li, W. et al. Dynamically monitoring cellular γ-H2AX reveals the potential of carcinogenicity evaluation for genotoxic compounds. Arch Toxicol 95, 3559–3573 (2021). https://doi.org/10.1007/s00204-021-03156-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-021-03156-3